Additionally, early indicators show benefits in cardiovascular markerspositioning these therapies as more than just glucose-lowering agents
Libraries were pooled and sequenced on a NovaSeq X sequencing system (Illumina)
Because different GLP-1 agonists have different FDA-labeled indications, they may be used for different reasons, such as type 2 diabetes or weight loss
Therefore, while GLP-1RAs may represent a promising therapeutic option for managing psoriasis, further high-quality studies are needed to distinguish whether the therapeutic effects of GLP-1RAs originate from the direct regulation of immune cells or improvements in comorbidities such as obesity or diabetes
Subcutaneous injections are administered into the fatty tissue just beneath the skin, most commonly in the abdomen, upper thigh, or upper arm
Is tirzepatide well studied